---
figid: PMC5877395__12929_2018_430_Fig1_HTML
figlink: /pmc/articles/PMC5877395/figure/Fig1/
number: F1
caption: Annexin A2 (ANXA2) in cancer progression. a The ANXA2-3-phosphoglycerate
  kinase (ANXA2-PGK) complex serves as a primer recognition protein to initiate DNA
  replication with the support from DNA polymerase alpha, which contributes to cell
  proliferation. b MIEN1 phosphorylates ANXA2 and supports ANXA2’s binding to actin
  filaments to modulate cytoskeletal change, thus resulting in cell migration. c ANXA2
  initiates the endothelial-mesenchymal transition (EMT) via the Twist/Snail pathway.
  After initiation of the EMT, cells changed to a mesenchymal-like morphology, and
  cell junctions dissolved. d The ANXA2 heterotetramer complex links to the plasminogen
  and tissue plasminogen activator (tPA). After plasminogen is cleaved into plasmin,
  plasmin activates pro-matrix metalloproteases (MMPs) to become MMPs. MMPs digest
  the extracellular matrix and fibronectin, thus resulting acceleration of invasion.
  e ANXA2 increases stemness-related transcription factors (Oct4, Sox2, and Nanog)
  through the Akt signaling pathway, which activates cancer stem cell formation
pmcid: PMC5877395
papertitle: Annexin A2-mediated cancer progression and therapeutic resistance in nasopharyngeal
  carcinoma.
reftext: Chang-Yu Chen, et al. J Biomed Sci. 2018;25:30.
pmc_ranked_result_index: '36599'
pathway_score: 0.9561524
filename: 12929_2018_430_Fig1_HTML.jpg
figtitle: Annexin A2 (ANXA2) in cancer progression
year: '2018'
organisms:
- Homo sapiens
ndex: e4253432-dee2-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5877395__12929_2018_430_Fig1_HTML.html
  '@type': Dataset
  description: Annexin A2 (ANXA2) in cancer progression. a The ANXA2-3-phosphoglycerate
    kinase (ANXA2-PGK) complex serves as a primer recognition protein to initiate
    DNA replication with the support from DNA polymerase alpha, which contributes
    to cell proliferation. b MIEN1 phosphorylates ANXA2 and supports ANXA2’s binding
    to actin filaments to modulate cytoskeletal change, thus resulting in cell migration.
    c ANXA2 initiates the endothelial-mesenchymal transition (EMT) via the Twist/Snail
    pathway. After initiation of the EMT, cells changed to a mesenchymal-like morphology,
    and cell junctions dissolved. d The ANXA2 heterotetramer complex links to the
    plasminogen and tissue plasminogen activator (tPA). After plasminogen is cleaved
    into plasmin, plasmin activates pro-matrix metalloproteases (MMPs) to become MMPs.
    MMPs digest the extracellular matrix and fibronectin, thus resulting acceleration
    of invasion. e ANXA2 increases stemness-related transcription factors (Oct4, Sox2,
    and Nanog) through the Akt signaling pathway, which activates cancer stem cell
    formation
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ACTC1
  - ACTG1
  - ACTB
  - AKT1
  - AKT2
  - AKT3
  - PLG
  - S100A10
  - SOX2
  - ACTG2
  - TWIST1
  - SNAI1
  - ACTA2
  - NANOG
  - CDH2
  - ACTA1
  - ANXA2
  - BSG
  - KAT5
  - POU5F1
  - MIEN1
  - Cancer
genes:
- word: Actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTC1
  entrez: '70'
- word: Actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTG1
  entrez: '71'
- word: Actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTB
  entrez: '60'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Plasmin
  symbol: PLG
  source: hgnc_symbol
  hgnc_symbol: PLG
  entrez: '5340'
- word: S100A10
  symbol: S100A10
  source: hgnc_symbol
  hgnc_symbol: S100A10
  entrez: '6281'
- word: Sox2
  symbol: SOX2
  source: hgnc_symbol
  hgnc_symbol: SOX2
  entrez: '6657'
- word: Actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTG2
  entrez: '72'
- word: Twist,Snail
  symbol: TWIST
  source: hgnc_prev_symbol
  hgnc_symbol: TWIST1
  entrez: '7291'
- word: Twist,Snail
  symbol: SNAIL
  source: hgnc_alias_symbol
  hgnc_symbol: SNAI1
  entrez: '6615'
- word: Actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTA2
  entrez: '59'
- word: Nanog
  symbol: NANOG
  source: hgnc_symbol
  hgnc_symbol: NANOG
  entrez: '79923'
- word: N-cadherin
  symbol: CDH2
  source: hgnc_symbol
  hgnc_symbol: CDH2
  entrez: '1000'
- word: Actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTA1
  entrez: '58'
- word: ANXA2
  symbol: ANXA2
  source: hgnc_symbol
  hgnc_symbol: ANXA2
  entrez: '302'
- word: CD147
  symbol: CD147
  source: hgnc_alias_symbol
  hgnc_symbol: BSG
  entrez: '682'
- word: CPLA2
  symbol: cPLA2
  source: hgnc_alias_symbol
  hgnc_symbol: KAT5
  entrez: '10524'
- word: Oct4
  symbol: Oct4
  source: hgnc_alias_symbol
  hgnc_symbol: POU5F1
  entrez: '5460'
- word: MIEN1
  symbol: MIEN1
  source: hgnc_symbol
  hgnc_symbol: MIEN1
  entrez: '84299'
chemicals: []
diseases:
- word: Cancer
  source: MESH
  identifier: D009369
figid_alias: PMC5877395__F1
redirect_from: /figures/PMC5877395__F1
figtype: Figure
---
